Source MDx is Awarded an SBIR Phase I Grant from the National Institutes of Health to Develop Biomarkers to Track (Hep C Chronic Fatigue)

Source MDx is Awarded an SBIR Phase I Grant from the National Institutes of Health to Develop Biomarkers to Track
[Press Release] PR Newswire via Yahoo! Finance - Jan 12 6:00 AM
Source MDx announced today that it has been awarded a Small Business Innovation Research grant by the National Institutes of Health to initiate the development of a molecular diagnostic test that will characterize Hepatitis C infected patients and their response to standard-of-care therapy.Save to My Web

Multivalent Prophylactic Vaccine for HCV and HBV infection
Pharmalicencing - Dec 22 10:59 AM
Hepatitis C virus (HCV) infection is a serious cause of liver disease, with more than 170 million people now chronically infected worldwide and at risk of developing liver cirrhosis and hepatocellular carcinoma.Save to My Web

ViroPharma to Present at the 24th Annual JPMorgan Healthcare Conference
[Press Release] PR Newswire via Yahoo! Finance - Jan 03 8:21 AM
ViroPharma Incorporated today announced that it will present at the JPMorgan 24th Annual Healthcare Conference, at 3:00 P.M. Pacific Time on January 9th, 2006.Save to My Web

Therapeutic Application of siRNAs for Hepatic Viral Diseases
Pharmalicencing - Dec 22 10:59 AM
RNA interference (RNAi) is a cytoplasmic gene-silencing mechanism induced by small interfering RNAs (siRNAs) for sequence-specific degradation of a target mRNA, and now widely accepted to be a highly promising therapeutic approach for pathogenic viruses, such as hepatitis virus and HIV.Save to My Web

New Vaccine for Hepatitis C in Development
RedNova - Jan 10 11:07 PM
Researchers say a new vaccine being tested on mice may one day help in the fight against hepatitis C.Save to My Web